Labaid Pharmaceuticals
Founded in 2013, this pharmaceutical manufacturer operates technologically advanced production facilities designed to comply with Good Manufacturing Practice and international regulatory standards (FDA, MHRA, TGA, WHO cGMP). The organization reports an in-house R&D capability and focuses on producing a range of pharmaceutical products including antibiotics, hormones, biopharmaceuticals, blood derivatives and transdermal patches. The company also describes commercial operations for branded products and states commitments to environmental management and sustainable business practices.
Industries
Nr. of Employees
Very Large (1000+)
Labaid Pharmaceuticals
Products
Algita D
Calcium (algae source) and vitamin D3 supplement.
Algita DX
Calcium (algae source) and vitamin D3 formulation.
Dexend
Dexlansoprazole (proton-pump inhibitor) formulation.
Cilvas
Cilnidipine (antihypertensive) formulation.
Comfy
Clonazepam formulation (anticonvulsant/anxiolytic).
Cephoral
Cefixime (oral antibiotic).
Algita D
Calcium (algae source) and vitamin D3 supplement.
Algita DX
Calcium (algae source) and vitamin D3 formulation.
Dexend
Dexlansoprazole (proton-pump inhibitor) formulation.
Cilvas
Cilnidipine (antihypertensive) formulation.
Comfy
Clonazepam formulation (anticonvulsant/anxiolytic).
Cephoral
Cefixime (oral antibiotic).
Expertise Areas
- GMP-compliant pharmaceutical manufacturing
- Biopharmaceutical and blood-derivative production
- Formulation and product development
- Regulatory compliance with international agencies
Key Technologies
- Biopharmaceutical manufacturing
- Transdermal patch formulation
- Oral solid dosage formulation
- Blood-derivative processing